🇺🇸 FDA
Patent

US 7465716

Targeted drug delivery with a hyaluronan ligand

granted A61KA61K47/6911A61K9/1271

Quick answer

US patent 7465716 (Targeted drug delivery with a hyaluronan ligand) held by The Regents of the University of California expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/6911, A61K9/1271